AgriFORCE Receives Australian Patent Allowance for Its High Fiber, High Protein Low Carbohydrate Flour and Technology
30 avr. 2024 08h30 HE
|
AgriFORCE Growing Systems Ltd.
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (IP) focused AgTech company, announces...
European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology
04 janv. 2024 08h00 HE
|
Indaptus Therapeutics
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biopharma company that utilizes a proprietary killed, non-pathogenic bacteria-based platform...
Aqua Security Granted Patent for Innovative Technology to Secure Serverless Container Environments
01 nov. 2023 08h00 HE
|
Aqua Security
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Aqua Security, the pioneer in cloud native security, today announced that it was granted a patent (11762986) for its MicroEnforcer technology to secure...
BioCardia Announces Helix™ Biotherapeutic Delivery Patent Issuance in Japan
08 juin 2023 07h00 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
Beam Global is Issued a European Patent for Compact Transportation-Configurable EV ARC™ Systems
11 mai 2023 08h00 HE
|
Beam Global
SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM, BEEMW), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy...
BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies
04 avr. 2023 07h00 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia Announces US Patent on Imaging System for Targeting Cardiac Therapies
15 juin 2022 08h00 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio
13 janv. 2022 08h30 HE
|
Brooklyn ImmunoTherapeutics, Inc.
NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and...
Palisade Bio Granted New U.S. Patent Covering Protease Inhibitor LB1148 for Treating Adhesions and Postoperative Ileus
08 déc. 2021 08h00 HE
|
Palisade Bio, Inc.
Issuance of Additional U.S. Patent No11,202,768 Further Bolsters Palisade Bio’s Patent Portfolio The Company Continues to Advance LB1148 for Key Indications After LB1148 Topline Efficacy Results from...
Skinopathy Files Provisional Patent for Artificial Intelligence and Augmented Reality Powered Technology that will Guide Skin Cancer Surgeries
02 févr. 2021 10h30 HE
|
Skinopathy
TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Skinopathy, a Canadian medical company founded in 2020, has filed a provisional patent with the United States Patent and Trademark Office (USPTO) for...